BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22683426)

  • 1. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.
    Stecklein SR; Jensen RA
    Transl Res; 2012 Sep; 160(3):178-97. PubMed ID: 22683426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.
    Kennedy RD; D'Andrea AD
    J Clin Oncol; 2006 Aug; 24(23):3799-808. PubMed ID: 16896009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
    Peremartí J; Ramos F; Marcos R; Hernández A
    Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
    Lyakhovich A; Surralles J
    Cancer Lett; 2006 Jan; 232(1):99-106. PubMed ID: 16246487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fanconi Anemia/BRCA pathway: new faces in the crowd.
    Kennedy RD; D'Andrea AD
    Genes Dev; 2005 Dec; 19(24):2925-40. PubMed ID: 16357213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of Fanconi anemia: FA-BRCA network -- review].
    Li YS; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):805-9. PubMed ID: 19549413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation.
    Powell SN; Kachnic LA
    Oncogene; 2003 Sep; 22(37):5784-91. PubMed ID: 12947386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the FA/BRCA pathway in bladder cancer.
    Neveling K; Kalb R; Florl AR; Herterich S; Friedl R; Hoehn H; Hader C; Hartmann FH; Nanda I; Steinlein C; Schmid M; Tonnies H; Hurst CD; Knowles MA; Hanenberg H; Schulz WA; Schindler D
    Cytogenet Genome Res; 2007; 118(2-4):166-76. PubMed ID: 18000367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.
    Mirchandani KD; D'Andrea AD
    Exp Cell Res; 2006 Aug; 312(14):2647-53. PubMed ID: 16859679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
    Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
    Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
    Barroso E; Pita G; Arias JI; Menendez P; Zamora P; Blanco M; Benitez J; Ribas G
    Breast Cancer Res Treat; 2009 Dec; 118(3):655-60. PubMed ID: 19536649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anaemia genes and susceptibility to cancer.
    Mathew CG
    Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.